1. Home
  2. PROK vs RC Comparison

PROK vs RC Comparison

Compare PROK & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.63

Market Cap

316.0M

Sector

Health Care

ML Signal

HOLD

Logo Ready Capital Corproation

RC

Ready Capital Corproation

HOLD

Current Price

$1.59

Market Cap

272.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROK
RC
Founded
2015
2007
Country
United States
United States
Employees
N/A
442
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
316.0M
272.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PROK
RC
Price
$1.63
$1.59
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$7.40
$2.81
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
2.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$893,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$67.36
P/E Ratio
N/A
N/A
Revenue Growth
1075.00
N/A
52 Week Low
$1.45
$1.39
52 Week High
$3.48
$4.47

Technical Indicators

Market Signals
Indicator
PROK
RC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
PROK
RC

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.

Share on Social Networks: